发明名称 Percutaneous absorption preparation
摘要 A percutaneous absorption preparation which is excellent in the skin penetration of a non-narcotic analgesic buprenorphine and can sustain a high blood level in a stable state over a long period of time is provided. The percutaneous absorption preparation for administrating buprenorphine hydrochloride and/or buprenorphine, which comprises a support having on one surface thereof a plaster layer containing a pressure-sensitive adhesive, buprenorphine hydrochloride and/or buprenorphine, and a penetration enhancer, wherein the penetration enhancer comprises a combination of a monoglyceride of a fatty acid having 6 to 8 carbon atoms and isopropyl myristate, and the plaster layer contains at least 10% by weight of a monoglyceride off fatty acid having 6 to 8 carbon atoms and at least 5% by weight off isopropyl myristate, with the proviso that the content of the whole penetration enhancer ranges from 25 to 50% by weight. The combined use of the fatty acid monoglyceride and isopropyl myristate as a penetration enhancer synergistically elevates skin penetration of buprenorphine hydrochloride and/or buprenorphine.
申请公布号 US5618555(A) 申请公布日期 1997.04.08
申请号 US19950430384 申请日期 1995.04.28
申请人 ITTO DENKO CORPORATION;NIKKEN CHEMICALS CO., LTD. 发明人 TOKUDA, SHOICHI;NINOMIYA, KAZUHISA;FUKUSHIMA, YASUHIRO;WATANABE, SHIGEYUKI;OCHIAI, MITSURU;OKUMURA, MUTSUO;HOSOKAWA, YUKO
分类号 A61K9/00;A61K9/70;A61K31/485;A61K47/14;A61P25/04;(IPC1-7):A61F13/00 主分类号 A61K9/00
代理机构 代理人
主权项
地址